000516.SHE Xian International Medical Investment Co Ltd
- Market cap
- CNY 10.1B
- P/E
- -
- P/B
- 3.03x
- ROE
- -2.9%
- Dividend yield
- 1.48%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 000516.SHE undervalued?
Graham numberThe Graham number of Xian International Medical Investment Co Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Xian International Medical Investment Co Ltd fundamental analysis
No fundamental analysis for Xian International Medical Investment Co Ltd yet.
Xian International Medical Investment Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Xian International Medical Investment Co Ltd
Xi'an International Medical Investment Company Limited provides healthcare services in China. It operates hospitals and medical centers. The company also engages in insurance broking, E-commerce, health and asset management, tourism, professional design, technological development, food and beverages, and pharmaceutical production business. The company was formerly known as Xi'an Kaiyuan Investment Group Co., Ltd. and changed its name to Xi'an International Medical Investment…
Full company profileXian International Medical Investment Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Xian International Medical Investment Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 3.93B | 4.06B | 2.04B | 991M | 1.61B | 2.92B | 2.71B | 4.62B | 4.82B | 4.07B | 4.11B |
| Gross Profit | 785M | 794M | 439M | 134M | -157M | 30.2M | -202M | 418M | 426M | 336M | 555M |
| Operating Income | 262M | 255M | 3.05B | -379M | 7.87M | -906M | -1.13B | -462M | -342M | -300M | -55.7M |
| EBITDA | 418M | 407M | 185M | -163M | -265M | -105M | -275M | 447M | 511M | 426M | -54.4M |
| Net Income | 202M | 195M | 2.18B | -404M | 45.4M | -822M | -1.18B | -368M | -254M | -313M | -93.8M |
| EPS | 0.10 | 0.10 | 1.11 | -0.21 | 0.02 | -0.37 | -0.52 | -0.16 | -0.11 | -0.14 | -0.04 |
| Balance Sheet | |||||||||||
| Total Assets | 5.56B | 5.83B | 7.31B | 10.0B | 12.1B | 13.3B | 13.3B | 11.3B | 10.6B | 9.71B | 9.22B |
| Total Liabilities | 2.06B | 2.20B | 1.53B | 5.03B | 7.09B | 7.99B | 9.01B | 7.51B | 7.16B | 6.70B | 6.35B |
| Shareholders' Equity | 3.49B | 3.62B | 5.73B | 4.96B | 5.00B | 5.33B | 4.25B | 3.91B | 3.67B | 3.32B | 3.25B |
| Cash & Short-term Investments | 2.67B | 1.95B | 1.44B | 1.39B | 1.55B | 1.81B | 1.34B | 1.08B | 680M | 411M | 370M |
| Total Debt | 1.03B | 961M | 712M | 3.41B | 4.62B | 5.10B | 4.47B | 3.98B | 3.82B | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 439M | 386M | -772M | -34.3M | 41.3M | 456M | 461M | 1.09B | 1.01B | 1.28B | - |
| Capital Expenditure | 227M | 894M | 1.70B | 3.61B | 1.34B | 1.66B | 1.19B | 763M | 548M | 262M | 239M |
| Free Cash Flow | 212M | -508M | -2.47B | -3.65B | -1.30B | -1.20B | -727M | 325M | 461M | 1.01B | 1.03B |
| Ratios | |||||||||||
| ROE | 5.8% | 5.4% | 38.1% | -8.2% | 0.9% | -15.4% | -27.7% | -9.4% | -6.9% | -9.4% | -2.9% |
| ROA | 3.6% | 3.3% | 29.9% | -4.0% | 0.4% | -6.2% | -8.9% | -3.3% | -2.4% | -3.2% | -1.0% |
| Net Profit Margin | 5.1% | 4.8% | 107.1% | -40.8% | 2.8% | -28.1% | -43.4% | -8.0% | -5.3% | -7.7% | -2.3% |
| Debt to Equity | 0.30x | 0.27x | 0.12x | 0.69x | 0.92x | 0.96x | 1.05x | 1.02x | 1.04x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Xian International Medical Investment Co Ltd dividends
- Dividend yield
- 1.48%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Jun 28, 2019
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 149M | 0.07 | - |
| 2024 | CNY 184M | 0.08 | - |
| 2023 | CNY 217M | 0.09 | - |
| 2022 | CNY 245M | 0.11 | - |
| 2021 | CNY 232M | 0.10 | - |
| 2020 | CNY 196M | 0.10 | 432.9% |
| 2019 | CNY 168M | 0.09 | - |
| 2018 | CNY 23.3M | 0.01 | 1.1% |
| 2017 | CNY 103M | 0.05 | 52.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 25:10 on May 19, 2016.
Who owns Xian International Medical Investment Co Ltd
- Insiders 33.19%
- Institutions 1.01%
- Public & others 65.80%
- Shares outstanding 2.24B
- Free float 1.55B
Xian International Medical Investment Co Ltd company profile
- Company name
- Xian International Medical Investment Co Ltd
- Ticker
- 000516.SHE
- ISIN
- CNE000000016
- Exchange
- Shenzhen Stock Exchange
- Listed since
- Jan 19, 1987
- Sector
- Healthcare
- Industry
- Broadline Retail
- Employees
- 8,055
- Fiscal year end
- December
- Address
- Security Building of Xi'an International Medical Center Hospital, Xi'an, China, 710100
- Phone
- 86 29 8833 2551
- Website
- 000516.cn
About Xian International Medical Investment Co Ltd
Xi'an International Medical Investment Company Limited provides healthcare services in China. It operates hospitals and medical centers. The company also engages in insurance broking, E-commerce, health and asset management, tourism, professional design, technological development, food and beverages, and pharmaceutical production business. The company was formerly known as Xi'an Kaiyuan Investment Group Co., Ltd. and changed its name to Xi'an International Medical Investment Company Limited in January 2015. Xi'an International Medical Investment Company Limited was founded in 1986 and is based in Xi'an, China.
Xian International Medical Investment Co Ltd management
8- Mr. Ruixuan LiuPresident & Director · born 1969
- Ms. Yaxing WangFinancial Director · born 1974
- Mr. Wen Guo SunVP & Director · born 1977
- Mr. Zhen DingVP & Board Secretary · born 1970
- Ms. Aiping WangVice President · born 1971
- Mr. Gao WangVice President · born 1970
- Mr. Yikuan SunVice President · born 1971
- Ziqi WeiHead of Accounting